The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate
- PMID: 339986
- DOI: 10.1111/j.1464-410x.1977.tb04559.x
The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate
Abstract
30 patients with oestrogen-escaped carcinoma of the prostate have been treated with estramustine phosphate (Estracyt). 27% showed a partial objective response and 33% had a subjective response. The terms used for defining a response are challenged and it is recommended that comparative controlled trials are necessary to judge the place of this drug in the management of advanced prostatic cancer.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources